ArticleGM crops & food2025
Science-based safety assessment of genetically modified DP915635 maize.
Article in GM crops & food, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Genetically modified maize event DP-915635-4 expressing the IPD079Ea protein was developed to control corn rootworm damage to maize plants. Utilizing a modernized safety assessment model published by CropLife International (CLI), the safety of DP-915635-4 maize was assessed. The CLI core studies included were molecular characterization of the inserted DNA, expression and characterization of the expressed IPD079Ea protein, and its safety for both food and feed use and the environment. No hazards were identified for human or animal consumption of DP-915635-4 maize containing the IPD079Ea protein, indicating that supplementary studies were not necessary. An environmental risk assessment was performed to characterize any potential impacts to non-target organisms, the results of which established that DP-915635-4 maize is unlikely to result in unreasonable adverse effects to non-target organisms. This case study shows that the modernized safety assessment is effective at demonstrating the safety of genetically modified crop plants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.